Iqvia Holdings (IQV) Total Non-Current Liabilities (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Total Non-Current Liabilities came in at $22.9 billion in Q2 2026, up 3.43% year-over-year from $22.2 billion in Q2 2025, and up 1.0% quarter-over-quarter from $22.7 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Total Non-Current Liabilities across 15 years of filings, most recently posting $22.9 billion for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities rose 3.43% year-over-year to $22.9 billion; the TTM figure through Jun 2026 stood at $22.9 billion (up 3.43% YoY), while the FY2025 annual figure was $22.6 billion, up 12.21% from the prior year.
- Total Non-Current Liabilities came in at $22.9 billion for Q2 2026 at Iqvia Holdings, up from $22.7 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $22.9 billion in Q2 2026 to a low of $18.3 billion in Q3 2022.
- Average Total Non-Current Liabilities over 5 years is $20.2 billion, with a median of $19.6 billion recorded in 2024.
- Year-over-year, Total Non-Current Liabilities declined 2.72% in 2024 and grew 16.39% in 2025.
- Over 5 years, Total Non-Current Liabilities stood at $18.9 billion in 2022, then gained by 5.13% to $19.9 billion in 2023, then climbed by 1.47% to $20.2 billion in 2024, then rose by 12.21% to $22.6 billion in 2025, then advanced by 1.37% to $22.9 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $22.9 billion in Q2 2026, $22.7 billion in Q1 2026, and $22.6 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 22.94 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 1.56 Bn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 6.94 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 4.24 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.15 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 30.49 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 553.39 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 28.62 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.94 Bn |
| Mar 31, 2026 | 22.71 Bn |
| Dec 31, 2025 | 22.63 Bn |
| Sep 30, 2025 | 21.74 Bn |
| Jun 30, 2025 | 22.18 Bn |
| Mar 31, 2025 | 20.66 Bn |
| Dec 31, 2024 | 20.16 Bn |
| Sep 30, 2024 | 19.60 Bn |
| Jun 30, 2024 | 19.05 Bn |
| Mar 31, 2024 | 19.64 Bn |
| Dec 31, 2023 | 19.87 Bn |
| Sep 30, 2023 | 19.49 Bn |
| Jun 30, 2023 | 19.59 Bn |
| Mar 31, 2023 | 19.17 Bn |
| Dec 31, 2022 | 18.90 Bn |
| Sep 30, 2022 | 18.32 Bn |
| Jun 30, 2022 | 18.50 Bn |
| Mar 31, 2022 | 18.47 Bn |
| Dec 31, 2021 | 18.00 Bn |
| Sep 30, 2021 | 17.55 Bn |